文献复现是非常重要的技能,能迅速模仿顶尖的研究也是不错的能力,中二的叫法就是“写轮眼”。
核心:
- 熟悉数据
- 大致知道基本的算法
- 知道分析核心的目的
复现第一篇:
The support of human genetic evidence for approved drug indications - NG
核心:一个卡方检验,所有的gene可以分为四类。
genetic evidence | None | |
FDA approval | ||
None |
指导意义:以后你找target,就优先去找有genetic evidence的gene,这样成功的概率更高。
知识点checkpoint:
- preclinical and clinical phases to launched drugs【一个药物获得FDA批准的大致流程】
- GWASdb(已关闭)和GWAS Catalog的数据类型,就是GWAS的lead SNP,每一行数据就是一个association
- Medical Subject Heading (MeSH) terms - treeView
数据:
- In the final data set, we had 18,566 genetic associations to 434 MeSH traits that mapped to 6,120 genes outside of the extended major histocompatibility complex (xMHC), with a total of 13,855 gene-trait combinations.
- Genes involved in rare, mendelian traits were derived from Online Mendelian Inheritance in Man (OMIM), providing a data set with 1,898 genes annotated to affect 2,145 traits with MeSH terms, for a total of 2,627 gene-trait combinations.
- 22,270 drugs known to modulate 1,824 human non-xMHC drug targets for 705 indications, giving a total of 19,085 target-indication pairs
附件数据: